Skip to main content
Vaishali Pharma Limited logo

Vaishali Pharma Limited — Investor Relations & Filings

Ticker · VAISHALI ISIN · INE972X01022 LEI · 335800LHHVE3JLLKP681 National Stock Exchange of India Wholesale and retail trade
Filings indexed 429 across all filing types
Latest filing 2020-09-15 Regulatory Filings
Country IN India
Listing National Stock Exchange of India VAISHALI

About Vaishali Pharma Limited

https://www.vaishalipharma.com/

Vaishali Pharma Limited specializes in the sourcing, marketing, and distribution of a comprehensive range of healthcare products. The company’s portfolio encompasses Active Pharmaceutical Ingredients (APIs), finished formulations in various dosage forms such as tablets and injectables, and surgical supplies. It also provides veterinary products, herbal supplements, and nutraceuticals. The business model focuses on integrated supply chain management, facilitating the movement of medical products from manufacturing units to global markets. By adhering to international quality standards and leveraging an extensive distribution network, the company serves diverse therapeutic requirements. Its operations emphasize reliability in procurement and the delivery of cost-effective healthcare solutions to a global clientele across multiple regions, including Africa, Asia, and Latin America.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Regulatory Filings
2020-09-15 English
Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure letter addressed to the National Stock Exchange of India, referencing SEBI regulations and circulars related to the impact of COVID-19 on the company. It provides detailed information about the material impact of the pandemic on the company's operations, financial resources, and future outlook. The document is a regulatory disclosure under SEBI Listing Obligations and Disclosure Requirements, specifically a material impact disclosure rather than a full financial report or earnings release. It does not contain financial statements or detailed financial results but is a compliance announcement about the pandemic's impact. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance document.
2020-09-10 English
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document contains multiple references to notices of board meetings and annual general meetings (AGMs), including newspaper advertisements and corrigenda related to the AGM notice. It also mentions the dispatch of the AGM notice and annual report to shareholders, and details about the AGM being held via video conferencing. There is no substantive financial data or detailed financial statements presented in the text, only references to the notice and report being sent or available on websites. The document is primarily an announcement related to the AGM notice and meeting arrangements rather than the full annual report or financial results themselves. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including notices and related announcements.
2020-09-09 English
Copy of Newspaper Publication
Regulatory Filings
2020-09-08 English
Updates
Regulatory Filings
2020-09-08 English
Book Closure
Regulatory Filings Classification · 90% confidence The document contains only placeholders for images and no textual content or financial data. It is extremely short (223 characters) and does not contain any report, announcement, or detailed information. Given the lack of content, it cannot be classified as a substantive report or announcement. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings without clear classification.
2020-09-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.